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Induction of mesangial interleukin-6 synthesis by apoptotic U937 cells
and monocytes. Infiltration of the glomerular mesangium by monocytes
and macrophages is a central pathologic feature in various forms of
glomerulonephritis. Dependent on the presence and activity of local
survival factors, monocytes may undergo apoptosis. Therefore, we looked
for the interaction between cultured human mesangial cells (HMC) and
intact, necrotic or apoptotic monocytic cells with different stages of
programmed cell death (U937 cells and blood-derived human m000cytes)
and the possible evoked secretory responses of HMC. Interleukin-6 (IL-6)
synthesis of HMC after a two hour co-culture with late apoptotic U937
cells was significantly increased (505 55 pg/mI) as compared to intact
U937 cells (349 27 pg/mI; HMC alone, 319 62 pg/mI), and was further
elevated after 20 hours (815 108 pg/mI). U937 cells alone, after
incubation in HMC-conditioned medium or after coincubation with
HMC, did not produce any detectable IL-6. A high mesangial IL-6
synthesis in response to apoptotic U937 cells was dependent on the
cellular contact between HMC and U937 and could not be mimicked by
apoptotic U937 culture supernatants. Radiolabeling studies indicated that
HMC bound (16.6 2.4%) and ingested (12.5 1.9%) apoptotic U937
cells to a much higher amount as compared to intact U937 (5.3 2.0%
binding; 5.0 1.1% phagocytosis). Binding and ingestion of monocytic
cells undergoing apoptosis was confirmed by morphologic studies using
electron microscopy. Incubation of HMC with a blocker of the CD36/
vitronectin receptor (VnR) dependent recognition mechanism of phago-
cytes for apoptotic leukocytes (RGDS peptide) did not alter binding,
phagocytosis or IL-6 synthesis of HMC in response to apoptotic U937.
Phospho-L-serine as an antagonist of the phosphatidylserine (PS) medi-
ated recognition pathway for apoptotic cell disposal was able to reduce
binding and IL-6 production by HMC but not phagocytosis. Thus, binding
of apoptotic monocytic cells by HMC rather than ingestion may be the
prerequisite for a stimulated secretory response. To elucidate whether
binding and phagocytosis of particles in general might stimulate HMC to
produce IL-fl, we looked for mesangial IL-6 production after binding and
ingestion of opsonized zymosan particles. In this case, IL-6 synthesis was
markedly down-regulated. Furthermore, HMC proliferated after zymosan
treatment, whereas after apoptotic cell uptake the mesangial cell number
remained constant. In conclusion, apoptotic monocytic cells provoked an
enhanced mesangial IL-6 synthesis by a PS-dependent recognition mech-
anism. This secretory response may have secondary implications for
humoral or cellular processes within the me.sangium.
Monocytes, macrophages and neutrophilic granulocytes invade
the mesangial space in many forms of acute and chronic glomer-
ulonephritis [1—31. Infiltration by leukocytes has been attributed
to glomerular injuty and sclerotic remodeling, since mononuclear
or polymorphonuclear cells generate and release a wide spectrum
of mediators that are able to promote further inflammation, cell
proliferation, matrix accumulation or tissue degradation [4—6].
For neutrophils it has been shown that intrinsic glomerular
mesangial cells are able to eliminate aged granulocytes by inges-
tion, which may be a process to reduce the cellular infiltration
within the mesangium [7]. Outside the mesangial space, apoptotic
neutrophils are normally removed via phagocytosis by macro-
phages as professional phagocytes [8, 91. A few studies have
demonstrated that the disposal of apoptotic leukocytes by macro-
phage phagocytosis is a way to bind toxic contents that is not
paralleled by secretory responses [10, 11]. Thus, elimination of
apoptotic cells is regarded as a mechanism of the immune system
to protect the organism against injury and to limit inflammation.
Also, monocytes are highly susceptible to programmed cell
death [12—14]. Apoptosis may occur constitutively during aging or
may be promoted or reverted by cytokines, growth factors or
inflammatory mediators [15, 16]. The fate of apoptotic monocytes
infiltrating the glomerulus and possible counteracting clearance
mechanisms by intrinsic mesangial cells have not been addressed
so far. The present study focuses on the interaction between
cultured human mesangial cells (HMC) and monocytic cells with
clearly defined features of apoptosis. It was of special interest to
investigate whether recognition and putative clearance of apopto-
tic monocytes by HMC may be a neutral event able to resolve
inflammation, or rather be accompanied by a secretory response
with possible secondary implications.
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Human recombinant IL-6, TNF-cs and GM-CSF were pur-
chased from Boehringer Mannheim GmbH (Mannheim, Ger-
many), FITC-labeled annexin V from Bender and Co. GmbH
(Vienna, Austria).
The tetrapeptides arg-gly-asp-ser (RGDS) and arg-gly-glu-ser
(RGES), phospho-L-serine, cycloheximide, zymosan A, pro-
pidium iodide (P1) and Hoechst 33258 stain were from Sigma
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Chemical Co. (St. Louis, MO, USA); culture media and supple-
ments were from Gibco BRL (Grand Island, MO, USA), and
tritium-labeled thymidine (spec. activity 5.0 Ci/mmol) from
Amersham Buchler (Braunschweig, Germany).
Cell culture
A single clone of SV40-transformed human glomerular mesan-
gial cells (HMC) between passages 3 and 10 was used throughout
this study. Mesangial cells were transfected with an origin-
defective SV4O early region by a standard procedure as described
previously [17]. For these cells and for HMC after a double
transfection with T-SV4O and H-ras oncogene, it has been shown
that characteristics similar to human mesangial cells derived from
primary cultures are exhibited with respect to morphology, con-
tractile properties, extracellular matrix formation and release of
IL-6 [18]. The clone of HMC used in our study showed uniform
fluorescence staining for actin, vimentin and collagen type IV and
negative staining for cytokeratin, desmin and von Willebrand
factor. Using a functional characterization, HMC revealed a
similar contractile response to angiotensin II as compared to
non-transfected mesangial cells and a similar IL-6 synthesis under
basal conditions or after stimulation with heat-aggregated im-
mune complexes. Cells were grown in DMEM culture medium
(DMEM-CM), supplemented with 50 U/mI penicillin, 50 j.Lg/ml
streptomycin, 1 mM L-glutamine and 0.5 to 5% heat-inactivated
(56°C, 30 mm) FCS at 37°C in a humidified 5% CO2 incubator.
The monocytic cell line U937, obtained from ATCC (Rockville,
MD, USA) was cultured in RPMI 1640 medium supplemented
with antibiotics, L-glutamine and 10% FCS and subcultured three
times weekly.
Human monocytes were isolated from 50 ml heparinized blood
from healthy donors by Ficoll-Hypaque density gradient centrif-
ugation and enriched by adherence on plastic culture plates as
described previously [14]. They had a purity of >90% as deter-
mined by staining for nonspecific esterase and were cultured in
medium as outlined for U937 cells.
Determination of apoptosis
The degree of apoptosis of the differently treated U937 cells
and monocytes was quantified using flow cytometry on a FACScan
flow cytometer (Becton Dickinson, Palo Alto, CA, USA) accord-
ing to previously described methods [19, 20]. Early apoptosis was
evaluated by labeling cells with FITC-annexin V, which specifi-
cally hinds to phosphatidylserine (PS) [19, 211. It has been
demonstrated that this negatively charged phospholipid moves
from the inner to the outer leaflet of the cell membrane during
early stages of apoptosis and so detection by annexin V might be
a suitable marker for programmed cell death [19, 22]. Further-
more, annexin V is a tool to study apoptotic alterations taking
place on the cell membrane surface, which may be the basis for
recognition of apoptotic cells by HMC.
Late stages of programmed cell death characterized by nuclear
degradation and apoptotic body formation of senescent cells were
visualized and quantified by counting under fluorescent micros-
copy after staining with Hoechst 33258 [231. In addition, differ-
ently treated U937 cells were characterized for apoptotic alter-
ations by propidium iodide (P1) staining [5 jg/ml in staining
buffer (SB), containing 1% bovine serum albumin in PBS, pH 7.4]
after permeabilization of cells with 0.1% saponin in SB using flow
cytometry. This procedure for the detection and quantification of
apoptosis is based on the principle that apoptotic cells exhibit a
reduced DNA stainability and accessibility to fiuorochromes after
permeabilization [24]. Cell size was simultaneously analyzed by
the amount of forward light scatter, cellular granulation by side
light scatter using UV light channel.
Evaluation of necrotic cell death was performed by staining
cells with 0.1% trypan blue for 10 minutes.
Induction of apoptosis
Induction of cellular alterations indicative for an early apopto-
tic stage was performed by culturing U937 cells in RPMI medium
without FCS for 12 hours, and then in phosphate buffered saline
(PBS) alone for the last 4 hours before the coculture with HMC.
Late stages of apoptosis with nuclear fragmentation were
achieved when U937 cells were treated with TNF-a (2 ng/ml) and
cycloheximide (0.5 tg/ml) for 4 hours according to a well estab-
lished protocol for apoptosis induction [251.
Cell necrosis was achieved by rapid freezing and thawing of
U937 cells.
In freshly isolated human monocytes constitutively occurring
apoptosis was markedly suppressed by culturing cells in 10% FCS
containing RPM! medium supplemented with GM-CSF (100
U/ml). Programmed cell death was induced by culturing cells in
medium without FCS for 24 hours.
Coculture of cells
HMC (1 x 105/ml) were growth arrested by culturing cells in
0.5% FCS containing DMEM-CM for 24 hours in a 24 well plate
(Falcon). HMC were washed and differently treated U937 cells or
monocytes (5 X 105/ml, HMC:monocytic cell ratio 1:5) resus-
pended in 2.5% FCS containing medium were added for 2 to 20
hours for determination of binding and phagocytosis or for
removal of culture supernatants.
To determine whether differently treated U937 cells might be
stimulated to produce IL-6 after cellular contact to HMC, cells
were cocultured for 20 hours and U937 cells were washed off the
mesangial cell layers and further incubated for another 20 hour
period at a density of 5 X 105/ml. U937 supernatants were then
collected for IL-6 determination.
Determination of IL-6
IL-6 concentration of culture supernatants (100 pd/well) was
measured by a highly specific enzyme immunoassay. Monoclonal
anti-rIL-6 antibody (5E1) for coating of plates was kindly pro-
vided by Dr. W. Buurman (Department of Medicine, University
Limburg, Maastricht, Germany). The secondary polyclonal anti-
rIL-6 antibody was generated by immunization of a rabbit with
rhIL-6 in Freund's complete adjuvant and isolation and purifica-
tion of IgG from sera by precipitation with (NH4)2S04 and anion
exchange chromatography. The secondary antibody was detected
by a horseradish peroxidase conjugated goat anti-rabbit IgG
(Jackson Immunoresearch Co., USA) using ABTS and H202 as
substrates. The lower detection limit was 0.5 pg/mi. The intra-
assay variability was below 5% and the inter-assay variability
below 10%.
Transmission electron microscopy
Binding and phagocytosis of intact and apoptotic U937 cells
and monocytes by HMC were visualized by electron microscopy as
previously described [14]. In brief, HMC were extensively washed
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to remove all unbound monocytic cells after the coculture,
tiypsinized, centrifuged and fixed in 1% glutaraldehyde-Na caco-
dylate HC1 0.1 M, pH 7.4. After postflxation in 1% osmium
tetraoxide, samples were dehydrated in an ascending ethanol
series and embedded in epoxy resin (Epon 812). Ultrathin sec-
tions were mounted on 150 mesh formvar copper grids and
poststained with aqueous saturated uranyl acetate and 2% lead
citrate before examined on a Philips CM 10 electron microscope
at an accelerating voltage of 60 kV.
Quantification of binding and phagocytosis of U937 cells by
HMC
U937 cells were labeled with 2 jtCi/ml [3H]-thymidine in 10%
FCS containing RPMI medium for 16 hours before induction of
apoptosis as described above. After extensive washing, U937 cells
in 2.5% FCS containing medium were added to quiescent HMC
cultures for 20 hours. For determination of the amount of U937
cells bound as well as ingested by HMC, cocultures were vigor-
ously washed with warm PBS for three times in order to remove
unbound cells. For quantification of phagocytosis of U937 cells by
HMC, a hypotonic lysis with H20 over five minutes followed the
intensive washing steps in order to lyse adherent but not ingested
U937 cells in the cocultures. This short-term hypotonic lysis has
been shown to let HMC remain intact. Thereafter, HMC were
lysed in 0.5 ml of 0.25% SDS and radioactivity was measured by
liquid scintillation spectroscopy.
The percentage of phagocytosis of HMC was calculated by the
following formula:
Phagocytosis (%) =
cpm ingested by HIMC — cpm bound to plastic plates><
total cpm added
Binding of U937 by HMC was calculated by subtracting radio-
activity due to phagocytosis from radioactivity measured after
washing off unbound U937 cells without hypotonic lysis. This
experimental protocol is adapted from previously published meth-
ods [26, 271.
When the antagonist of the CD36/vitronectin receptor (VnR)
recognition mechanism of apoptotic cell phagocytosis RGDS (1
mM) was used, HMC were pretreated for two hours with this
blocker or the inactive control RGES. The same procedure was
employed when the PS-dependent recognition pathway was an-
tagonized by phospho-L-serine (1 mM).
Treatment of HMC with opsonized zymosan and determination
of HMC proliferation
Zymosan A was boiled for 30 minutes, washed three times in
PBS and incubated with fresh human AB serum at a concentra-
tion of 10 mg/ml for 30 minutes at 37°C. After extensive washing,
opsonized zymosan particles were resuspended in DMEM-CM
and used at a final concentration of 100 zg/ml [28]. Zymosan
treated with heated serum was used as a negative control. After 30
minutes of treatment of HMC, zymosan that was not bound or
phagocytosed was washed off and HMC further incubated for 20
hours for obtaining culture supernatants, which were analyzed for
IL-6 content by using ELISA.
For determination of proliferation, HMC cocultured with intact
or late apoptotic U937 cells for 20 hours were extensively washed
Table 1. Determination of apoptosis and necrosis of U937 cells and
human monocytes
Designation/
treatment of cells
Early apoptotic
(annexin V)
Late apoptoti
(Hoechst 33258
c Necrotic cells) (trypan blue)
U937/10% FCA <5 <5 <5
U937/without FCS 25 5 21 6 <5
U937apo/TNF
a + cyclohex.
39 8 36 5 <5
U93700/freezing and <5 <5 85 11
thawing
Monocyte/1O% 11 6 <5 <5
FCS + GM-CSF
Monocytep0/without 29 8 17 6 <5
FCS
Data are means SEM. Quantification of apoptosis has been performed
by FACS analysis (annexin V) or fluorescent microscopy (Hoechst 33258),
or necrosis by counting trypan blue positive cells by light microscopy as
described in the Methods section. U937 are early apoptotic, U937apo late
apoptotic and U937ncro are necrotic U937 cells.
Monocyteapo stands for apoptotic human monocytes.
Five independent cultures have been analyzed.
to remove all of the non-ingested U937 cells, and afterwards
pulsed with 2 jCi/ml [3H-thymidine in 1.5% FCS containing
medium for 12 hours. After washing and trypzination, HMC were
harvested onto filter paper by an automated cell harvester as
previously described [29]. Incorporated counts were measured
using a liquid scintillation counter. In order to exclude that
incorporation of radioactivity was affected by adherent apoptotic
U937 cells left on HMC layers in spite of washing, mesangial cell
numbers were also assessed by counting under a light microscope
using a Neubauer chamber. Evaluation of mesangial growth after
treatment with zymosan particles was identically determined by
[3H]-thymidine incorporation and cell counting.
Statistical analysis
All data are presented as mean standard error. Statistical
analysis was performed using Student's I-test for unpaired sam-
ples. P values less than 0.05 were considered to be significant.
RESULTS
Induction of apoptosis in U937 cells and monocytes
To investigate the interaction between HMC and apoptotic
monocytic cells, U937 cells with different stages of programmed
cell death were used for the coculture. Labeling of PS exposure by
annexin V was regarded as a marker for early apoptosis, whereas
late apoptosis was assumed when U937 cells showed nuclear
condensation or degradation by Hoechst 33258 staining. Further-
more, cell size, granulation and DNA stainability with PT were
determined by flow cytometry. As indicated in Table 1, 25 5%
of U937 cells cultured without serum bound annexin V. Cell size
decreased after serum deprivation, and granulation and propor-
tion of cells showed low DNA staining with P1 after permeabili-
zation increased as compared to intact cells (Fig. 1). After
TNF-a/cycloheximide treatment proportion of apoptotic U937
cells further increased, which showed features of late apoptosis
with nuclear fragmentation by positive Hoechst 33258 staining
(36 5% positive cells; Table 1). Compared to early apoptotic
cells, the amount of shrunken cells rose (34%), and 25% of U937
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Fig. 1. Cell size, cellular granulation and DNA stainability by propidium
iodide (P1) of normal (U937), early apoptotic (U937a) and late apoptotic(U9370) U937 cells as detected by flow cytometry. Cell sizes and
proportion of cells with shrinkage have been determined by the amount of
forward light scatter and are shown in the histograms at the left side.
Apoptotic cells were further characterized by increased side light scatter,
reflecting cellular granulation, and reduced DNA stainability by PT using
permeabilized cells (graphs at the right side). A typical experiment out of
three is depicted.
Fig. 2. IL-6 contents of culture supernatants derived from HMC cocul-
tured in the absence or presence of normal (U937), early apoptotic
(U937), late apoptotic (U9370) or necrotic (U937..,,) U937 cells for 2
hours (A) or 20 hours (B). Differently treated U937 cells alone did not
release any IL-6 into culture supernatants, so that the measured lL-6
activity was attributable solely to HMC. Data are means SaM from six
independent experiments with fourfold cultures. p < 0,05, p < 0.001
compared to HMC incubated only with medium.
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cells revealed reduced DNA staining with PT (Fig. 1). All apopto-
tic U937 cells excluded trypan dye to more than 95%, ruling out
necrosis.
Intact human monocytes cultured in 10% FCS and GM-CSF
containing medium were labeled by annexin V in 11 6%,
whereas apoptotic monocytes cultured in FCS-free medium
showed positive staining with annexin V and Hoechst 33258 to
much higher degrees (Table 1).
IL-6 synthesis of HMC during coculture with apoptotic U937
cells
As shown in Figure 2A, HMC cocultured with late apoptotic
U937 cells for the last 2 hours during a 20-hour culture period
produced significantly more IL-6 (505 55 pg/mI) as compared to
HMC cocultured without (319 62 pg/mI) or with intact or early
apoptotic cells. For comparison, necrotic U937 cells were also
included, which further stimulated IL-6 synthesis of HMC (412
26 pg/mI). All the IL-6 activity measured in the coculture super-
natants could be attributed to mesangial sources exclusively as
outlined below (Table 2).
When monocytic cells were co-cultured with HMC over 20
hours (Fig. 2B), intact, early apoptotic as well as necrotic U937
cells enhanced IL-6 production by HMC. The coculture with late
apoptotic U937 cells increased HMC-derived IL-6 synthesis mark-
edly (815 108 pg/mI) and to a statistically higher level as
compared to intact, early apoptotic or necrotic U937 cells.
/
E
'a
0
a0 0 0N. N. N. N.
CO C') C') CO0) 0) 0) 0)
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Celis'
Interleukin-6 pg/mi
Basal
HMC-conditioned
mediumb
after HMC
contactc
U937 <5 332±16 <5
U937a <5 344 18 <5
U937apo
U937nro
<5
<5
353 19
363 22
<5
<5
Data are means SEM, N = 12.
U937 cell designation and treatment is identical as explained in Table
1 and in the Methods section.
h Supernatants from HMC (1 x 105/ml), cultured in 0.5% FCS contain-
ing DMEM medium for 24 hr, were used for incubation of differently
treated U937 cells. IL-6 content of HMC supernatants without U937 cells
was 358 21 pg/ml.
U937 cells were carefully washed off HMC layers and incubated alone
as described in the Methods section.
Exclusion of IL-6 synthesis by U937 cells
As shown in Table 2, intact, early and late apoptotic as well as
necrotic U937 cells did not produce any IL-6 when cells were
cultured alone. After incubation of U937 cells in HMC-condi-
tioned medium, similar IL-6 concentrations were detected as
compared to HMC cultures without U937. After cellular contact
with HMC and a subsequent culture of differently pretreated
U937 cells alone, no significant IL-6 contents were analyzed in
culture supernatants.
These experiments indicated that the measured IL-6 immuno-
activity from the HMC/U937 cocultures came from mesangial
sources and excluded U937 activation for cytokine synthesis by
HMC.
Effects of U937 culture supernatants on IL-6 synthesis by HMC
To judge whether enhanced IL-6 synthesis by HMC during the
coculture with apoptotic U937 cells was dependent on a cellular
interaction and contact between HMC and monocytic cells, we
also tested IL-6 synthesis by 1-TIMC incubated with supernatants of
the differently treated U937 cells for 20 hours. As shown in Figure
3, neither supernatants from intact nor from early or late apopto-
tic U937 cells had any influence on basal mesangial cell IL-6
production. Interestingly, only the enhanced IL-6 synthesis by
HMC co-cultured with necrotic U937 could be mimicked by
incubating HMC with the supernatants from lyscd U937 cells.
This implies that in the case of monocytic apoptosis, a cellular
contact with HMC may be obligatory for a stimulated secretory
response of mesangial cells, whereas in the case of monocytic
necrosis soluble compounds may have the capacity to increase
cytokine release from HMC.
Morphological analysis of the cellular interaction between
HMC and apoptotic U937 cells or monocytes
HMC cocultured with intact or late apoptotic U937 cells for 20
hours were observed by transmission electron microscopy to
evaluate binding and ingestion. Binding was presumed when
monocytic cells showed a direct contact to the HMC membrane
despite extensive washing. When at least 50 HMC were counted,
below 3% of HMC showed binding of intact U937 cells. In
contrast, 19 8% of HMC revealed adjacent U937 cells when late
apoptotic cells were used for the 20 hours of coculture (data not
shown). Phagocytosis was presumed when monocytic cells were
inside the HMC cytoplasm. Below 3% of evaluated HMC showed
ingestion of intact U937 cells, whereas 11 4% of the HMC had
ingested late apoptotic U937 cells or apoptotic bodies. Figure 4A
depicts a typical electron micrograph showing a late apoptotic
U937 cell after phagocytosis by a HMC.
Morphological studies were also performed after coculturing
HMC with intact or apoptotic human blood-derived monocytes.
Of all the counted HMC only 12 7% bound to intact monocytes,
whereas the proportion of HMC significantly increased (24 8%,
P < 0.05) when apoptotic monocyte binding was compared. A
typical image is given in Figure 4B, where presumably tight
binding is depicted between a HMC and a monocyte with
advanced features of apoptosis, and loose binding of a monocyte
with early apoptotic alterations is also shown. Phagocytosis of
intact monoeytes occurred in <3% of counted HMC but was
found in 9 3% of HMC after coculture with apoptotic mono-
cytes (P < 0.05). A typical image is presented in the Figure 4C,
where a mesangial phagosome is visible containing an apoptotic
human monocyte.
Determination of binding and uptake of apoptotic U937 cells by
HMC
Binding and phagocytosis of intact versus late apoptotic U937
cells by HMC was quantified by a radiolabel assay after a 20 hour
coculture. Figure 5A shows that binding of apoptotic U937 cells
by HMC (16.6 2.4%) was significantly increased as compared to
binding of intact U937 cells (5.3 2.0%). Similarly, uptake of late
apoptotic U937 cells by HMC (12.5 1.9%) exceeded phagocy-
tosis of normal U937 cells (5.0 1.1%; Fig. SB).
Table 2. Interleukin-6 synthesis of intact (U937), early apoptotic
(U937), late apoptotic (U937ap0) and necrotic (U937rcro) U937 cells
under basal conditions, in HMC-conditioned medium, or after coculture
with HMC
*
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Fig. 3. IL-6 contents of culture supernatants after incubating HMC with
medium or supernatants derived from normal (U937), early apoptotic
(U937), late apoptotic (U9370) or necrotic (U937..,cro) U937 cells for 20
hours. Means SEM are given from three independent experiments with
fourfold cultures. *p < 0.05 compared to HMC cultured in medium alone.
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Fig. 4. Evidence of uptake and binding of apoptotic monocytic cells by
HMC. Typical electron micrographs show a HMC after ingestion of a late
apoptotic U937 cell ( ; A), a HMC binding two blood-derived human
monocytes (MO) with different stages of apoptosis (B) and a mesangial
phagosome containing an apoptotic human monocyte (MO; C). Morpho-
logic characterization has been performed after a 20 hour coculture with
subsequent vigorous washing (bar = 1 sm).
U937 U937apo.
Fig. 5. Determination of binding (A) and phagocytosis (B) of intact
(U937) versus late apoptotic (U9370) U937 cells by HMC after 20 hours.
Data are means SEM from three independent experiments with fourfold
cultures. tP < 0.05 compared to U937.
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Analysis of the recognition mechanism of HMC for apoptotic
U937 cells
Consequently, it was important to determine what kind of
recognition pathway was employed by HMC for binding and
uptake of apoptotic monocytic cells. The RGDS tetrapeptide able
to antagonize the thrombospondin bridged CD36/VnR integrin
recognition mechanism of phagocytes for apoptotic cells [301 was
incapable of reducing binding or phagocytosis of late apoptotic
U937 cells by HMC (Figure 6 A, B). The RGES peptide had no
influence on phagocyte-apoptotic cell interaction and was in-
cluded as a negative control. On the other hand, phospho-L-
serine, which inhibits the PS-mediated recognition of apoptotic
cells [31, 321, significantly reduced binding of late apoptotic U937
cells by HMC from 18.8 1.1% to 11.0 1.7% (Fig. 6A).
Phagocytosis of apoptotic U937 cells was slightly but not signifi-
cantly reduced by phospho-L-serine treatment of HMC (9.1
1.8% vs. 12.9 2.2% for medium control; Fig. 6B).
Influence of blocking the PS-dependent recognition of apoptotic
1)937 cells by HMC on IL-6 synthesis
It was of interest to find out whether inhibition of the binding
of late apoptotic U937 cells by HMC in response to phospho-L-
serine might also abrogate mesangial IL-6 production. The
blocker of the CD36!VnR recognition pathway was also tested. At
first it was excluded that treatment of HMC with RGDS, RGES
or phospho-L-serine (I m, respectively) had any influence on
basal mesangial IL-6 synthesis without co-culturing apoptotic
U937 cells (Fig. 7A). As presented in Figure 7B, treatment of
HMC with phospho-L-serine significantly down-regulated IL-6
production when HMC were co-cultured with late apoptotic U937
cells for 20 hours (760 81 pg/mI as compared to 1103 283
pglml for medium control). The tetrapeptides RGDS and RGES
had no influence on mesangial IL-6 synthesis in response to
apoptotic monocytic cells.
IL-6 production by HMC in response to zymosan treatment
HMC were then treated with zymosan to determine whether
binding and phagocytosis of small particles is followed by stimu-
lated IL-6 synthesis in any case, or rather, may reflect a specific
mesangial response to apoptotic monocyte recognition. Morpho-
logical analysis revealed that HMC effectively bound and ingested
opsonized zymosan particles, whereas zymosan preincubated with
heated serum was not phagocytosed (data not shown).
As presented in Table 3, binding and uptake of opsonized
zymosan significantly down-regulated mesangial IL-6 production
(167 24 pg/mI vs. 325 42 pg/mI IL-6 in HMC alone, P < 0.01).
Inactive zymosan, however, did not affect mesangial IL-6 synthe-
sis.
Proliferation of HMC after apoptotic U937 cell recognition or
zymosan treatment
We further determined HMC growth after the coculture with
intact or late apoptotic U937 cells to look at whether apoptotic
cell recognition might lead to proliferation or to damage of
mesangial cells. As shown in Table 3, neither intact nor apoptotic
U937 cells affected mesangial growth as analyzed by thymidine
incorporation or cell counting. Apoptosis of HMC after contact
with apoptotic rnonocytic cells was excluded in electron micros-
copy studies where typical alterations of HMC were never oh-
—2 Cl) (/)0 UJ
o 0 0o o__J
—2 w to0 UJ
o 0 0o o__J
Fig. 6. Percentage of binding (A) and phagocytosis (B) of late apoptotic
U937 cells by HMC after 20 hours. HMC were pretreated with the indicated
substances (1 mrvt each) for 2 hours and during the coculture with apoptotic
U937 cells before measuring binding and phagocytosis by a radiolabeled
assay. Data are means SEM from four independent experiments with
fourfold cultures. < 0.05 compared to control medium.
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Fig. 7. IL-6 contents of culture supernatants from HMC treated with
RGDS, RGES peptide or phospho.L-serine (1 m, respectively) alone (A)
or in coculture with late apoptotic U937 cells (B) for20 hours. Data are
means SEM; N = 12. p < 0.05 compared to control.
served (Fig. 4 A-C). In contrast, a significant increase of prolifer-
ation was detected when HMC were treated with opsonized
zymosan (Table 3), suggesting that mesangial responses after
interaction with solid particles as compared to apoptotic cell
compounds might be substantially different.
Increase of mesangial IL-6 production by the co-culture with
human monocytes
To obtain an insight into the possible relevance of the presented
results for human disease, we also examined the interaction
between HMC and intact versus apoptotic blood-derived human
monocytes. As indicated in Table 1, intact monocytes showed
small hut significant degrees of positive Annexin V staining,
whereas apoptotic monocytes exhibited marked staining by An-
nexin V and Hoechst 33258. It was not possible to culture human
monocytes without baseline signs of early apoptosis. As explained
above and depicted in Figure 4B and 4C, HMC bound and
incorporated apoptotic monocytes better than intact monocytes.
Cytokine determination of supernatants from cocultures showed
that IL-6 production by HMC (388 59 pg/mI) was potentiated
when cells were cocultured with intact (1804 182 pg/mI) or
apoptotic monocytes (1620 115 pg/ml; Fig. 8). There was no
significant difference between mesangial IL-6 synthesis in re-
sponse to the coculture with intact versus apoptotic monocytes.
However, normal but not apoptotic human monocytes produced
significant amounts of IL-6 (142 87 pg/ml) by themselves. We
assume that the potentiated IL-6 production following coculture
of HMC with apoptotic monocytes can be exclusively attributed to
the mesangial cells.
DISCUSSION
In this in vitro study, we examined whether monocytic cells with
clearly defined features of apoptosis induced inflammatory re-
sponses following their interaction with mesangial cells. During
inflammatory glomerular diseases, an invasion of monocytes and
neutrophils into the mesangial space is frequently observed and
has been attributed to glomerular injury and scarring [1, 2]. Data
are available showing that macrophages ingesting aged neutro-
phils do not exert secretory responses with respect to thrombox-
ane B2 and granule enzyme release [10]. Furthermore, Savill and
coworkers have addressed this field by showing phagocytosis of
apoptotic neutrophils by glomerular mesangial cells in vitro and in
vivo [71. The key finding of the present study is that apoptotic
monocytic cells are recognized, bound and partially ingested by
HMC, in parallel with an exaggerated mesangial IL-6 production.
Late apoptotic but not early apoptotic U937 cells were already
able to stimulate IL-6 synthesis after a 2 hour coculture with
HMc. Late apoptotic U937 cells exerted a greater nuclear
fragmentation in Hoechst 33258 staining, surface PS exposure and
granulation, but smaller cell size as compared to early apoptotic
cells; all are alterations that may facilitate apoptotic cell recogni-
tion and ingestion. We think that a distinction between early and
late apoptotic cells with a detailed characterization is important
because only late apoptotic U937 cells exhibited pronounced
mesangial responses. Early apoptotic cells were rather similar to
intact monocytic cells, so that exclusive usage of growth factor
depleted U937 cells would have obscured the described effects.
We used U937 cells as a model for monocytic cells because they
show many functional characteristics of monocytes and macro-
phages [33] without producing IL-6 by themselves [34]. We were
also able to exclude U937 activation for IL-6 synthesis by HMC-
derived culture supernatants or after direct cellular contact with
HMC. This allowed us to attribute the measured IL-6 activity
exclusively to mesangial sources. Furthermore, in contrast to
freshly isolated human monocytes, different stages of pro-
grammed cell death could be induced in U937 cells by defined
treatment protocols yielding the so-called early and late apoptotic
cells.
In addition to assessing mesangial IL-6 production by measur-
ing IL-6 immunoactivity in culture supernatants by ELISA, we
also performed Northern blot analysis and rtPCR assays for
detecting mesangial IL-6 message. However, these procedures
were not successful because of technical reasons. HMC could not
be cleared from surface-bound and ingested apoptotic monocytic
cells before the isolation of mesangial RNA. Samples of mesan-
gial cells after the coculture with apoptotic U937 cells were
"contaminated" with monocytic RNA so that loading gels with
equal amounts of mRNA from HMC was not reliable. Enhanced
levels of IL-6 after the coculture between HMC and apoptotic
cells was attributable to de novo lL-6 synthesis by HMC, because
preincubation of HMC with cycloheximide (1 to 10 rg/ml) highly
reduced cytokine production (data not shown).
The inability of culture supernatants from apoptotic U937 cells
to induce mesangial IL-6 synthesis proved that a cellular contact
between I-IMC and monocytic cells was obligatory for stimulation
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Table 3. Phagocytosis, IL-6 production and proliferation of HMC, cocultured with intact or apoptotic (apo) U937 cells, or with heated (heat) or
opsonized (ops) zymosan particles
Cells
Binding and
phagocytosis
IL-6
pg/mi
Proliferationa
Incorporated cpm
Mesangial cell count
(x 10)
HMC alone — 325 42 21,092 665 104 8
HMC + U937 no 402 30" 19,550 795 105 9
HMC + U937ap0HMC + zymosan50,
HMC + zymosan,,
yes
no
yes
836 88C
278 35
167 24C
18,228 1,789
21,977 809
24,979 434b
100 7
108 11
122 7b
Data are means SEM, N = 10.
a Proliferation of HMC was determined by [3H]-thymidine incorporation as explained in the Methods section, or by microscopical cell counting
"p < 0.05, cp < 0.01 compared to HMC alone
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Fig. 8. IL-6 contents of HMC supernatants cocultured or not with
normal (MO) or apoptotic (MOapo) blood-derived human monocytes for
20 hours. Also, IL-6 contents of MO and MOapo cultures are depicted
alone. Means SEM are given; N = 12. *p < 0.05 compared to HMC
alone, P < 0.05 compared to MO alone.
of cytokine synthesis. The mechanism by which HMC recognized
bound and ingested apoptotic U937 cells was further investigated
by using antagonists of well-characterized recognition pathways of
phagocytes for senescent cells [30—32, 35]. Binding of apoptotic
U937 cells was inhibited by phospho-L-serine, a blocker of the PS
receptor that can attach PS, which is externalized by a flip-flop
translocation of the plasma membrane during programmed cell
death [21, 31, 361. Since binding of senescent U937 cells but not
phagocytosis was down-regulated by phospho-L-serine in parallel
with a blunted IL-6 synthesis, we suggest that binding of apoptotic
cells by HMC may be more crucial for the initiation of an
inflammatory response than ingestion. Besides this, the RGDS
tetrapeptide, which is able to block the CD36/VnR dependent
recognition pathway used by macrophages for the removal of aged
neutrophils, was tested [30, 37]. Since it was unable to decrease
binding or ingestion of apoptotic monocytic cells by HMC, it is
assumed that glomerular mesangial cells as semiprofessional
phagocytes do not use the same receptors as macrophages to
remove unwanted cells. Currently, the PS dependent recognition
mechanism has been preferentially attributed to the clearance of
apoptotic lymphocytes and the VnR dependent process to the
clearance of aged neutrophils [22, 30]. Data on the receptors
involved in the removal of apoptotic monocytes by non-apoptotic
phagocytes are not available. Cellular events of HMC being
involved in recognition of necrotic U937 cells or monocytes were
not examined in the present study. Uptake of necrotic U937 cells
by HMC could be observed (data not shown) as it has been shown
for apoptotic human monocytes (Fig. 4C). Because of the special
relevance of the interaction between HMC and blood-derived
monocytes for human disease, experiments dealing with this
aspect are currently performed.
Several previous studies have demonstrated binding of U937
cells or other leukocytes by adhesion molecules such as ICAM-1
or VCAM-1 expressed on activated HMC [4, 38, 39]. A marked
binding of non-apoptotic leukocytes, however, was dependent on
an activation of mesangial cells by mediators such as LPS, TNF-a
or chemotactic peptides. Thus, mesangial cells are equipped with
a spectrum of various receptors and adhesion molecules that
facilitate invasion and accumulation of leukocytes in the mesan-
gium during inflammatory states. Which receptors HMC uses to
initiate ingestion and definitive disposal of apoptotic leukocytes in
order to participate in the resolution of inflammation warrants
further investigation.
Studies using opsonized zymosan A as a source of particles able
to be bound and ingested by HMC were included to prove the
specificity of enhanced mesangial IL-6 synthesis after apoptotic
cell recognition. Results excluded that binding and phagocytosis
of small particles by HMC was followed by a stimulated IL-6
production per Se. Furthermore, substantial differences in HMC
proliferation were detected after the contact of HMC with
apoptotic cells or opsonized zymosan particles. In the case of
apoptotic cell recognition, the HMC number remained constant,
but after zymosan treatment HMC proliferated.
Experiments applying blood-derived human monocytes instead
*
*
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of U937 cells for the coculture with HMC showed a highly
potentiated mesangial IL-6 synthesis. Monocytes undergoing ap-
optosis did not enhance IL-6 production by HMC further as
compared to intact monocytes. One explanation is that the highly
stimulated IL-6 production already obtained after the incubation
of HMC with intact monocytes may have reached the maximum
capacity of mesangial cells for cytokine synthesis. Besides this,
intact monocytes always showed some features of early apoptosis
with positive annexin V staining as well as binding to HMC in
culture, which may be sufficient to trigger IL-6 production by
specific receptors. It is also noteworthy that in the cocultures of
HMC with apoptotic monocytes all the IL-6 immunoactivity came
from mesangial sources, whereas in samples after the coculture
with intact monocytes IL-6 was derived both from the mesangial
as well as from the monocytic compartments.
The present study describing enhanced IL-6 synthesis by HMC
after contact with apoptotic U937 cells or monocytes was not
designed to assess the consequences of the pronounced cytokine
synthesis. Several previous studies have addressed the question
whether IL-6 acts as an anti-inflammatoty or pro-inflammatory
mediator in the inflamed glomerulus [40]. In vitro, IL-6 has been
shown to stimulate or to inhibit growth of mesangial cells [41, 42].
In vivo, Horii et al [43] demonstrated an involvement of IL-6 in
patients with mesangioproliferative glomerulonephritis, whereas
in an animal model for antibody-mediated glomerular injury, IL-6
injection reduced proteinuria and leukocyte infiltration of the
glomerulus [44]. Since IL-6 has been attributed to enhanced
mesangial matrix accumulation and enlargement [45], it is con-
ceivable that clearance of apoptotic cells may be the beginning of
a sclerotic reorganization due to a secondary secretory response
of HMC.
In summary, our data demonstrate the recognition and partial
removal of apoptotic monocytes by HMC in parallel with an
enhanced IL-6 production. Hence, apoptotic cell disposal may not
achieve the limitation of an inflammation in every case, but may
evoke secondary reactions within the inflamed glomerulus.
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